Voglibose 0.3mg + Metformin 500mg SR
Product Details:
- Drug Type Other Types
- Physical Form Tablets
- Dosage Guidelines After Food
- Quantity 500 Boxes
- Storage Instructions store in a cool & dry ,dark plase
- Click to View more
Voglibose 0.3mg + Metformin 500mg SR Price And Quantity
Voglibose 0.3mg + Metformin 500mg SR Product Specifications
- Other Types
- After Food
- 500 Boxes
- Tablets
- store in a cool & dry ,dark plase
Voglibose 0.3mg + Metformin 500mg SR Trade Information
- Cash Against Delivery (CAD), Cash Advance (CA)
- As Per Market Demand Per Day
- 30/45 Days
- Within a certain price range free samples are available
- 10*10
- All India
Product Description
Uses of Voglibose 0.3mg + Metformin 500mg:
Voglibose Is Used In The Treatment Of Diabetes. Voglibose Reduces Absorption Of Glucose From The Intestine And Thus Lowers Post-Prandial Glucose Level . Metformin Also Helps In Reducing Higher Blood Glucose Level.
Side Effects of Voglibose 0.3mg + Metformin 500mg:
Flatulence; Abdominal Distension; Diarrhoea; Pain; Skin Reactions; Hypoglycemia; Increased LFT. Potentially Fatal: Hepatotoxicity.
Drug Interactions of Voglibose 0.3mg + Metformin 500mg:
May Enhance Effects Of Other Antidiabetics Including Insulin.
Contraindications of Voglibose 0.3mg + Metformin 500mg:
Inflammatory Bowel Disease; GI Obstruction Or Patients Predisposed To It; Conditions Which May Deteriorate As A Result Of Increased Gas Formation Eg, Hernia; Severe Ketosis; Diabetic Coma Or Pre-Coma; Severe Infection; Hypersensitivity; Pregnancy; Lactation. Not To Be Used As Monotherapy In IDDM.
Mechanism of Action of Voglibose 0.3mg + Metformin 500mg:
Voligbose Has General Properties Similar To Acarbose And Selectively Inhibits Α-Glucosidase In The Enteric Canal, Delaying The Digestion And Absorption Of Carbohydrate, Thereby Suppressing Sharp Increase In Post-Prandial Plasma Glucose.
Special Precautions for Voglibose 0.3mg + Metformin 500mg:
History Of Laparotomy Or Ileus. Roemheld's Syndrome, Stenosis, Severe Hepatic Or Renal Impairment. Child <18 Yr; Elderly. Monitor LFT. Treat Hypoglycaemic Episodes With Glucose (Not With Sucrose).